NORTH AMERICA GENETIC TESTING MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • NORTH AMERICA GENETIC TESTING MARKET FORECAST 2019-2027

NORTH AMERICA GENETIC TESTING MARKET FORECAST 2019-2027

The North America Genetic Testing Market was valued at $XX million in 2018 and is expected to reach $XX million by 2027 with a CAGR of 10.59% during the forecast period. The growing aging population in the region is also driving the growth in the North American Market. The economies of the United States and Canada are the major trendsetters in the North American market for genetic testing.

NORTH AMERICA GENETIC TESTING MARKET FORECAST 2019-2027

North America Genetic Testing Market by Technology (Cytogenetic Testing, Biochemical Testing, Molecular Testing) by Type (Carrier Testing, Diagnostic Testing, Newborn Screening, Predictive and Presymptomatic Testing, Prenatal Testing, Other Types) by Disease (Alzheimer’s Disease, Cancer, Cystic Fibrosis, Sickle Cell Anemia, Duchenne Muscular Dystrophy, Thalassemia, Huntington’s Disease, Rare Diseases, Other Diseases) by Geography.

Request free sample

Genetic testing is experiencing a huge shift from general diagnostics to risk assessment situations. Moreover, a personalized medicine which is the ‘need of the decade’ is rapidly becoming a reality, with a continuous surge in biotechnological advancements and life science tools.

The North America Genetic Testing Market was valued at $XX million in 2018 and is expected to reach $XX million by 2027 with a CAGR of 10.74% during the forecast period. The growing aging population in the region is also driving the growth in the North American Market.

The market in North America is majorly driven by the presence of key players such as Genentech and Oxford Biomedical in the biotechnology industry, who are investing largely for the development of the new technologies that can be used in the development of new testing techniques and advancement of the existing ones. But still, there are some challenges which are being faced by the North American region. These include monetary obstructions due to the high cost of the production of technology.

The economies of the United States and Canada are the major trendsetters in the North American market for genetic testing. The growing healthcare spending by the US is one of the major factors which is pushing the growth in the US genetic testing market.

Genentech, Inc., Illumina, Inc., Danahar Corporation (Cepheid), Genomictree, Inc., Roche Diagnostics Corporation, Pacific Biosciences of California, Inc., Integragen S.A, Bio-Rad Laboratories, Inc., HTG Molecular Diagnostics, Inc., Myriad Genetics, Inc., DAAN Diagnostics Ltd., Laboratory Corporation of America Holdings, 23ANDME, Abbott Laboratories, Oxford Biodynamics Limited, Luminex Corporation, Qiagen N.V., Natera, Inc., and PerkinElmer, Inc., have been the major market players which have been thoroughly profiled in the report.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP-DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • MOLECULAR TESTING IS THE FASTEST GROWING GENETIC TESTING TECHNOLOGY
      • CANCER MARKET HOLDS THE LARGEST MARKET SHARE IN TERMS OF DISEASE
      • DIAGNOSTIC TESTING IS THE WIDELY USED GENETIC TESTING TYPE
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVER
      • GROWING USAGE OF DIAGNOSING GENETIC DISORDERS
      • RISE IN INCIDENCE OF GENETIC DISEASES
      • MINIMAL HEALTH RISK ASSOCIATED WITH GENETIC TESTING
      • SURGE IN RNA PIPELINE TESTS
      • ADVANCES IN GENETIC TESTING FOR CANCER
      • GROWING AGING POPULATION
    • MARKET RESTRAINTS
      • INACCURACIES IN RESULTS
      • REIMBURSEMENT ISSUES
      • PSYCHOLOGICAL IMPACT
      • LACK OF PRECISION IN TESTING
    • MARKET OPPORTUNITIES
      • GENETIC COUNSELLING
      • RISING CLINICAL APPLICATION FOR GENETIC TESTING
      • INNOVATION IN THE TREATMENT AND DIAGNOSTIC
    • MARKET CHALLENGES
      • HIGH COST OF MEDICATION AND TESTS
      • HIGH COST OF RAW MATERIAL
      • RISE IN GENETIC DISCRIMINATION
  1. MARKET BY TECHNOLOGY
    • CYTOGENETIC TESTING
    • BIOCHEMICAL TESTING
    • MOLECULAR TESTING
  2. MARKET BY TYPE
    • CARRIER TESTING
    • DIAGNOSTIC TESTING
    • NEWBORN SCREENING
    • PREDICTIVE AND PRESYMPTOMATIC TESTING
    • PRENATAL TESTING
    • OTHER TYPES
  3. MARKET BY DISEASE
    • ALZHEIMER’S DISEASE
    • CANCER
    • CYSTIC FIBROSIS
    • SICKLE CELL ANEMIA
    • DUCHENNE MUSCULAR DYSTROPHY
    • THALASSEMIA
    • HUNTINGTON’S DISEASE
    • RARE DISEASES
    • OTHER DISEASES
  4. KEY ANALYTICS
    • PORTER’S FIVE FORCES ANALYSIS
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTES
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
      • THREAT OF RIVALRY
    • KEY BUYING CRITERIA
      • COST
      • ACCURACY
      • AVAILABILITY
      • RELIABILITY
    • MARKET TRENDS
      • HEALTH INFORMATION IS RISING SIGNIFICANTLY
      • INCREASING DEMAND FOR PERSONALIZED MEDICINE
      • NEW PRODUCT LAUNCHES
      • TECHNOLOGY ADVANCEMENTS
    • PESTEL ANALYSIS
    • OPPORTUNITY MATRIX
  5. GEOGRAPHIC ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
  1. COMPANY PROFILING
    • 23ANDME
    • ABBOTT LABORATORIES
    • BIO-RAD LABORATORIES, INC.
    • DANAHER CORPORATION (CEPHEID)
    • DAAN DIAGNOSTICS LTD.
    • GENENTECH, INC.
    • HTG MOLECULAR DIAGNOSTICS, INC.
    • ILLUMINA, INC.
    • LABORATORY CORPORATION OF AMERICA HOLDINGS
    • LUMINEX CORPORATION
    • MYRIAD GENETICS, INC.
    • NATERA, INC.
    • OXFORD BIODYNAMICS LIMITED
    • PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
    • PERKINELMER, INC.
    • QIAGEN N.V.
    • ROCHE DIAGNOSTICS CORPORATION

TABLE LIST

TABLE 1        NORTH AMERICA GENETIC TESTING MARKET 2019-2027 ($ MILLION)

TABLE 2        COST OF SELECTED DRUGS IN CANCER THERAPY

TABLE 3        NORTH AMERICA GENETIC TESTING MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)

TABLE 4        NORTH AMERICA CYTOGENETIC TESTING MARKET 2019-2027 ($ MILLION)

TABLE 5        NORTH AMERICA BIOCHEMICAL TESTING MARKET 2019-2027 ($ MILLION)

TABLE 6        NORTH AMERICA MOLECULAR TESTING MARKET 2019-2027 ($ MILLION)

TABLE 7        NORTH AMERICA GENETIC TESTING MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 8        NORTH AMERICA CARRIER TESTING MARKET 2019-2027 ($ MILLION)

TABLE 9        NORTH AMERICA DIAGNOSTIC TESTING MARKET 2019-2027 ($ MILLION)

TABLE 10      NORTH AMERICA NEWBORN SCREENING MARKET 2019-2027 ($ MILLION)

TABLE 11      NORTH AMERICA PREDICTIVE AND PRESYMPTOMATIC TESTING MARKET 2019-2027 ($ MILLION)

TABLE 12      NORTH AMERICA PRENATAL TESTING MARKET 2019-2027 ($ MILLION)

TABLE 13      NORTH AMERICA OTHER TYPES MARKET 2019-2027 ($ MILLION)

TABLE 14      NORTH AMERICA GENETIC TESTING MARKET BY DISEASE 2019-2027 ($ MILLION)

TABLE 15      NORTH AMERICA ALZHEIMER’S DISEASE MARKET 2019-2027 ($ MILLION)

TABLE 16      NORTH AMERICA CANCER MARKET 2019-2027 ($ MILLION)

TABLE 17      NORTH AMERICA CYSTIC FIBROSIS MARKET 2019-2027 ($ MILLION)

TABLE 18      NORTH AMERICA SICKLE CELL ANEMIA MARKET 2019-2027 ($ MILLION)

TABLE 19      NORTH AMERICA DUCHENNE MUSCULAR DYSTROPHY MARKET 2019-2027 ($ MILLION)

TABLE 20      NORTH AMERICA THALASSEMIA MARKET 2019-2027 ($ MILLION)

TABLE 21      NORTH AMERICA HUNTINGTON’S DISEASE MARKET 2019-2027 ($ MILLION)

TABLE 22      NORTH AMERICA RARE DISEASES MARKET 2019-2027 ($ MILLION)

TABLE 23      NORTH AMERICA OTHER DISEASES MARKET 2019-2027 ($ MILLION)

TABLE 24      NORTH AMERICA GENETIC TESTING MARKET BY COUNTRY 2019-2027 ($ MILLION)

FIGURES LIST

FIGURE 1      NORTH AMERICA GENETIC TESTING MARKET 2019-2027 ($ MILLION)

FIGURE 2      SAMPLES TYPES IN GENETIC TESTING

FIGURE 3      LAB AUTOMATION TECHNOLOGY BENEFITS GENETIC DIAGNOSTIC INDUSTRIES

FIGURE 4      NORTH AMERICA GENETIC TESTING MARKET SHARE BY TECHNOLOGY 2018 & 2027 (%)

FIGURE 5      NORTH AMERICA GENETIC TESTING MARKET BY CYTOGENETIC TESTING 2019-2027 ($ MILLION)

FIGURE 6      NORTH AMERICA GENETIC TESTING MARKET BY BIOCHEMICAL TESTING 2019-2027 ($ MILLION)

FIGURE 7      NORTH AMERICA GENETIC TESTING MARKET BY MOLECULAR TESTING 2019-2027 ($ MILLION)

FIGURE 8      NORTH AMERICA GENETIC TESTING MARKET SHARE BY TYPE 2018 & 2027 (%)

FIGURE 9      NORTH AMERICA GENETIC TESTING MARKET BY CARRIER TESTING 2019-2027 ($ MILLION)

FIGURE 10   NORTH AMERICA GENETIC TESTING MARKET BY DIAGNOSTIC TESTING 2019-2027 ($ MILLION)

FIGURE 11   NORTH AMERICA GENETIC TESTING MARKET BY NEWBORN SCREENING 2019-2027 ($ MILLION)

FIGURE 12   NORTH AMERICA GENETIC TESTING MARKET BY PREDICTIVE AND PRESYMPTOMATIC TESTING 2019-2027 ($ MILLION)

FIGURE 13   NORTH AMERICA GENETIC TESTING MARKET BY PRENATAL TESTING 2019-2027 ($ MILLION)

FIGURE 14   NORTH AMERICA GENETIC TESTING MARKET BY OTHER TYPES 2019-2027 ($ MILLION)

FIGURE 15   NORTH AMERICA GENETIC TESTING MARKET SHARE BY DISEASE 2018 & 2027 (%)

FIGURE 16   NORTH AMERICA GENETIC TESTING MARKET BY ALZHEIMER’S DISEASE 2019-2027 ($ MILLION)

FIGURE 17   NORTH AMERICA GENETIC TESTING MARKET BY CANCER 2019-2027 ($ MILLION)

FIGURE 18   NORTH AMERICA GENETIC TESTING MARKET BY CYSTIC FIBROSIS 2019-2027 ($ MILLION)

FIGURE 19   NORTH AMERICA GENETIC TESTING MARKET BY SICKLE CELL ANEMIA 2019-2027 ($ MILLION)

FIGURE 20   NORTH AMERICA GENETIC TESTING MARKET BY DUCHENNE MUSCULAR DYSTROPHY 2019-2027 ($ MILLION)

FIGURE 21   NORTH AMERICA GENETIC TESTING MARKET BY THALASSEMIA 2019-2027 ($ MILLION)

FIGURE 22   NORTH AMERICA GENETIC TESTING MARKET BY HUNTINGTON’S DISEASE 2019-2027 ($ MILLION)

FIGURE 23   NORTH AMERICA GENETIC TESTING MARKET BY RARE DISEASES 2019-2027 ($ MILLION)

FIGURE 24   NORTH AMERICA GENETIC TESTING MARKET BY OTHER DISEASES 2019-2027 ($ MILLION)

FIGURE 25   PORTER’S FIVE FORCE MODEL

FIGURE 26   HEALTHCARE EXPENDITURE IN THE U.S. 2014 & 2025 (% OF GDP)

FIGURE 27   THE UNITED STATES GENETIC TESTING MARKET 2019-2027 ($ MILLION)

FIGURE 28   CANADA GENETIC TESTING MARKET 2019-2027 ($ MILLION)

  1. GEOGRAPHIC ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
  1. MARKET BY TECHNOLOGY
    • CYTOGENETIC TESTING
    • BIOCHEMICAL TESTING
    • MOLECULAR TESTING
  2. MARKET BY TYPE
    • CARRIER TESTING
    • DIAGNOSTIC TESTING
    • NEWBORN SCREENING
    • PREDICTIVE AND PRESYMPTOMATIC TESTING
    • PRENATAL TESTING
    • OTHER TYPES
  3. MARKET BY DISEASE
    • ALZHEIMER’S DISEASE
    • CANCER
    • CYSTIC FIBROSIS
    • SICKLE CELL ANEMIA
    • DUCHENNE MUSCULAR DYSTROPHY
    • THALASSEMIA
    • HUNTINGTON’S DISEASE
    • RARE DISEASES
    • OTHER DISEASES

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now